PepsiCo Faces Pressure From Elliott Targets as GLP-1 Threat Grows
PepsiCo is approaching a critical test of its turnaround strategy as the company prepares to report third-quarter results, with pressure mounting from both activist-investor expectations and changing consumer habits linked to GLP-1 weight-loss drugs.
The food and beverage giant has spent the past year responding to pressure from Elliott Investment Management, which disclosed a roughly $4 billion investment in PepsiCo in September 2025 and pushed for stronger growth, better margins and greater accountability. Nearly a year later, investors are still waiting for clear evidence that the strategy is reversing weakness in PepsiCo's core North American snacks business.
The timing is becoming more important because PepsiCo is also confronting a structural question: can one of the world's biggest snack and beverage companies continue growing when consumers are increasingly focused on protein, fiber, portion control and healthier eating?
PepsiCo's third-quarter earnings, due Thursday, could provide some of the clearest clues yet.
Elliott's Targets Put PepsiCo Under Pressure
Elliott's involvement was not simply about cutting costs. Its September 2025 presentation argued that PepsiCo could become a faster-growing, higher-margin and more valuable consumer-goods company through greater focus, operational improvements, strategic reinvestment and stronger accountability.
PepsiCo subsequently announced a plan supported by Elliott that included sharper pricing, more product innovation, aggressive productivity savings and a review of its North American supply chain and go-to-market model.
The company set a particularly important financial objective: at least 100 basis points of core operating-margin expansion over three fiscal years. A basis point is one-hundredth of a percentage point, so 100 basis points equals one percentage point.
PepsiCo also targeted 2% to 4% organic revenue growth for 2026 and expected core constant-currency EPS growth of roughly 4% to 6% in its preliminary outlook.
The problem is that the margin trajectory has not yet moved in the required direction.
Margin Improvement Is Still Elusive
Through the first half of 2026, PepsiCo's core operating margin was 16.3%, down 15 basis points from a year earlier. That is significant because the company is trying to deliver at least 100 basis points of cumulative margin expansion over the three-year period.
PepsiCo has not been standing still.
The company has closed manufacturing plants, shut production lines, reduced its U.S. product range and pursued automation, digitalization and other productivity measures. It has also tried to make popular products such as Lay's and Doritos more affordable after demand weakened.
But cost savings alone cannot permanently solve the problem if volumes and market share remain under pressure.
That is particularly important for PepsiCo Foods North America, where Frito-Lay is a major earnings engine.
The GLP-1 Threat Changes the Consumer Equation
The emergence of GLP-1 weight-loss medicines adds another layer of uncertainty.
Drugs such as semaglutide and tirzepatide can reduce appetite and have been associated with changes in eating patterns. For food companies, the concern is not necessarily that consumers will stop buying snacks altogether. The larger question is whether people taking these medicines—or consumers influenced by the broader weight-management trend—will buy fewer calories, smaller portions or more nutritious alternatives.
That matters for PepsiCo because its portfolio has historically been heavily exposed to salty snacks and sugary beverages.
The company has responded by expanding products positioned around protein, fiber, functional benefits and portion control. Its innovation pipeline includes products such as Doritos Protein, SunChips Fiber and Good Warrior beef sticks.
This is strategically important because PepsiCo is attempting to adapt its existing brands rather than simply abandon the categories that built its business.
The challenge is speed.
Consumer preferences can change faster than a large multinational can reformulate products, change manufacturing systems and establish new brands.
PepsiCo Is Already Moving Toward Healthier Products
The company has been preparing for the shift for some time.
PepsiCo's strategy includes products with more protein, fiber and whole grains, while also reducing artificial colors and flavors across parts of its portfolio. The company said in December that it planned to launch Doritos Protein and reduce nearly 20% of U.S. SKUs as part of its broader effort to simplify operations and improve productivity.
Its 2026 product strategy has also emphasized functional beverages and emerging categories.
That gives PepsiCo an advantage that smaller food companies may not have: distribution.
A healthier snack does not automatically become a major business simply because consumers like the concept. It needs shelf space, advertising, manufacturing capacity and retailer relationships. PepsiCo already possesses those assets.
The question is whether the company can use them quickly enough to offset weakness in legacy products.
Q2 Showed Some Encouraging Signs—but Not a Full Turnaround
PepsiCo's second-quarter results provide a mixed picture.
Net revenue increased 6.4% to $24.18 billion, while organic revenue rose 2.4%. Core EPS increased 4% year over year. The company also said global organic volume was growing at its fastest rate since 2022, helped by international operations and portfolio changes.
There was also improvement in North American convenient-food volumes, with PepsiCo reporting volume market-share gains supported by innovation and affordability initiatives.
However, the core operating margin remained under pressure. PepsiCo's first-half core operating margin was 16.3%, compared with 16.5% a year earlier.
That explains why investors are likely to look beyond headline revenue growth when the company reports on Thursday.
The key question is whether revenue growth is translating into sustainable volume improvement and margin expansion.
What Analysts Are Watching in Q3
According to LSEG data cited by Reuters, analysts expect PepsiCo's third-quarter revenue to rise about 4.3% to $24.96 billion, while adjusted EPS is expected to increase only around 0.21% to approximately $2.29.
Those expectations suggest investors are not looking for spectacular growth.
Instead, the market wants evidence that the deterioration in North American snacks is stabilizing.
Investors will likely pay particular attention to:
North American snack volumes
Frito-Lay market share
Pricing versus volume trends
Core operating margin
Productivity savings
PepsiCo's beverage performance
Progress in protein, fiber and functional products
Management's comments on GLP-1-related consumer behavior
The outlook for the remainder of 2026
The distinction between price growth and volume growth will be especially important. A company can increase revenue by raising prices, but if customers buy fewer units as a result, the strategy may eventually become difficult to sustain.
PepsiCo's Stock Performance Reflects Investor Frustration
Investor patience is becoming another issue.
PepsiCo shares have fallen nearly 12% this year and are about 16% below their level around the time of Elliott's investment, according to Reuters.
That does not mean Elliott's strategy has failed. Turnarounds in a company as large as PepsiCo can take years, particularly when the business is simultaneously dealing with inflation, changing consumer preferences and commodity costs.
But the share-price performance shows why the upcoming earnings report matters.
If PepsiCo can demonstrate improving volumes and a credible path toward margin expansion, investors may become more confident that the company's restructuring is gaining traction.
If the North American snacks business remains weak, pressure for faster action could intensify.
Why the GLP-1 Risk Is Different From Normal Inflation
Inflation is usually cyclical. When food and energy costs fall or consumer purchasing power improves, demand can recover.
The GLP-1 issue is potentially more structural.
If weight-loss medicines contribute to a long-term shift toward smaller portions and healthier food choices, snack companies may need to redesign their portfolios rather than simply wait for consumers to return.
That does not automatically mean PepsiCo's traditional brands will collapse. Lay's, Doritos and Pepsi remain enormous consumer franchises with strong distribution and brand recognition.
Instead, the risk is that future growth increasingly comes from healthier and functional products while older categories grow more slowly.
For PepsiCo, successfully managing that transition without sacrificing margins could become one of the defining challenges of its next phase.
What Investors Should Watch Next
The immediate catalyst is PepsiCo's third-quarter earnings report.
The most important number may not be revenue. Investors need to see whether North American volumes are stabilizing and whether productivity savings are beginning to translate into genuine core-margin improvement.
Management's late-2026 update on North American supply-chain and go-to-market optimization will also be important because PepsiCo has identified those initiatives as part of its shareholder-value strategy.
Beyond the next earnings report, the market will be watching whether PepsiCo's healthier innovations gain meaningful distribution and repeat purchases.
That is the real test of the GLP-1 response. Launching protein or fiber products is relatively easy; building a large, profitable consumer franchise around them is much harder.
Bottom Line
PepsiCo is facing a two-sided challenge: it must deliver the growth and margin improvements associated with its Elliott-supported turnaround while simultaneously adapting to a consumer environment increasingly shaped by health, weight management and GLP-1 drugs.
The company has already taken significant steps on pricing, productivity, portfolio simplification and healthier product innovation. Its second-quarter results also showed some encouraging volume trends globally.
But the North American margin trajectory remains a concern, and investors have yet to see enough evidence that the turnaround is firmly established.
Thursday's earnings report should therefore be judged less on whether PepsiCo simply beats or misses estimates and more on whether management can show sustainable volume recovery, improving margins and a credible response to changing consumer demand.
For investors, those trends will matter more than any single quarter.
Follow the blog for more stock-market, consumer-business and global company updates.
This article is for informational and educational purposes only and should not be considered investment advice.